EUVIMEDEUVIMED entdecken
Fallbericht

Clinical Significance of Molecular Genetic Analysis in Diffuse Intrinsic Pontine Glioma: Two Case Reports

Itsuki Inamine iD, Kohei Fukuoka, Kayoko Ichimura, Yuichi Mitani iD, Daiju Oba, Kaishi Satomi, Kagehiro Kouzuki, Mamoru Honda, Koichi Oshima, Makiko Mori, Yutaka Tanami, Masao Kobayashi und 5 weitere

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70043 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Itsuki Inamine und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan. Hauptthemen laut MEDLINE: Diffuse Intrinsic Pontine Glioma, Brain Stem Neoplasms, Tumor Suppressor Protein p53. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prognosis of diffuse intrinsic pontine glioma (DIPG) is dismal, with no established curative treatments. While DIPG frequently harbors diagnostically significant H3F3A mutations, it typically lacks molecularly targetable genetic abnormalities. Due to the tumor's location and the associated risks of morbidity and mortality from tissue sampling, standard care has traditionally relied on clinical symptoms and imaging for diagnosis and treatment decisions—even at recurrence—without biopsy. Herein, we present two cases of DIPG in which biopsy of disseminated lesions at recurrence revealed clinically significant genetic alterations, including high tumor mutational burden or a germline TP53 mutation. These findings underscore the potential clinical value of molecular genetic analysis from biopsied tissues, which may inform treatment decisions and guide patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diffuse Intrinsic Pontine GliomaBrain Stem NeoplasmsTumor Suppressor Protein p53HumansMaleFemalePrognosisChildMutationClinical Relevance

Stichwörter der Autor:innen

Li–Fraumeni syndromebiopsydiffuse intrinsic pontine gliomahigh tumor mutational burden

Substanzen

TP53 protein, humanTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.
  • Department of Pathology, Saitama Children's Medical Center, Saitama, Japan.
  • Division of Medical Genetics, Saitama Children's Medical Center, Saitama, Japan.
  • Department of Pathology, Kyorin University Faculty of Medicine, Tokyo, Japan.
  • Department of Radiology, Saitama Children's Medical Center, Saitama, Japan.
  • Department of Radiation Oncology, Jikei University School of Medicine, Tokyo, Japan.

ORCID-Profile: Itsuki Inamine, Yuichi Mitani, Noriko Watanabe, Katsuyoshi Koh

Zitieren

APA

Inamine, I., Fukuoka, K., Ichimura, K., Mitani, Y., Oba, D., Satomi, K., Kouzuki, K., Honda, M., Oshima, K., Mori, M., Tanami, Y., Kobayashi, M., Ohashi, H., Watanabe, N., Arakawa, Y., Kurihara, J., & Koh, K. (2026). Clinical Significance of Molecular Genetic Analysis in Diffuse Intrinsic Pontine Glioma: Two Case Reports. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70043

Vancouver

Inamine I, Fukuoka K, Ichimura K, Mitani Y, Oba D, Satomi K, et al. Clinical Significance of Molecular Genetic Analysis in Diffuse Intrinsic Pontine Glioma: Two Case Reports. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70043

BibTeX
@article{Inamine2026,
  author = {Inamine, Itsuki and Fukuoka, Kohei and Ichimura, Kayoko and Mitani, Yuichi and Oba, Daiju and Satomi, Kaishi and Kouzuki, Kagehiro and Honda, Mamoru and Oshima, Koichi and Mori, Makiko and Tanami, Yutaka and Kobayashi, Masao and Ohashi, Hirohumi and Watanabe, Noriko and Arakawa, Yuki and Kurihara, Jun and Koh, Katsuyoshi},
  title = {Clinical Significance of Molecular Genetic Analysis in Diffuse Intrinsic Pontine Glioma: Two Case Reports},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70043}
}
Kostenlos starten →